HC Wainwright & Co. Reiterates Buy on Disc Medicine, Maintains $118 Price Target

Benzinga · 07/03 11:16
HC Wainwright & Co. analyst Douglas Tsao reiterates Disc Medicine (NASDAQ:IRON) with a Buy and maintains $118 price target.